146 related articles for article (PubMed ID: 10575334)
21. Tiotropium and simplified detection of dynamic hyperinflation.
Gelb AF; Taylor CF; McClean PA; Shinar CM; Rodrigues MT; Gutierrez CA; Chapman KR; Zamel N
Chest; 2007 Mar; 131(3):690-695. PubMed ID: 17356081
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
23. Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study.
Pelkonen M; Notkola IL; Tukiainen H; Tervahauta M; Tuomilehto J; Nissinen A
Thorax; 2001 Sep; 56(9):703-7. PubMed ID: 11514691
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters.
Eberly LE; Ockene J; Sherwin R; Yang L; Kuller L;
Int J Epidemiol; 2003 Aug; 32(4):592-9. PubMed ID: 12913035
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study.
Panettieri RA; MacIntyre N; Sims M; Kerwin E; Fogarty C; Noonan M; Claus R; Andrews WT
Clin Ther; 2009 Aug; 31(8):1716-23. PubMed ID: 19808130
[TBL] [Abstract][Full Text] [Related]
26. High-resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD.
D'Anna SE; Asnaghi R; Caramori G; Appendini L; Rizzo M; Cavallaro C; Marino G; Cappello F; Balbi B; Di Stefano A
Respiration; 2012; 83(5):383-90. PubMed ID: 21832824
[TBL] [Abstract][Full Text] [Related]
27. Use of the forced oscillation technique to assess airway obstruction and reversibility in children.
Delacourt C; Lorino H; Herve-Guillot M; Reinert P; Harf A; Housset B
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):730-6. PubMed ID: 10712315
[TBL] [Abstract][Full Text] [Related]
28. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
Islam SS; Schottenfeld D
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
[TBL] [Abstract][Full Text] [Related]
29. Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease.
Drummond MB; Hansel NN; Connett JE; Scanlon PD; Tashkin DP; Wise RA
Am J Respir Crit Care Med; 2012 Jun; 185(12):1301-6. PubMed ID: 22561963
[TBL] [Abstract][Full Text] [Related]
30. The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma.
O'Byrne PM; Lamm CJ; Busse WW; Tan WC; Pedersen S;
Chest; 2009 Dec; 136(6):1514-1520. PubMed ID: 19710291
[TBL] [Abstract][Full Text] [Related]
31. T2* measurements of 3-T MRI with ultrashort TEs: capabilities of pulmonary function assessment and clinical stage classification in smokers.
Ohno Y; Koyama H; Yoshikawa T; Matsumoto K; Takahashi M; Van Cauteren M; Sugimura K
AJR Am J Roentgenol; 2011 Aug; 197(2):W279-85. PubMed ID: 21785054
[TBL] [Abstract][Full Text] [Related]
32. Bronchodilator reversibility testing in chronic obstructive pulmonary disease.
Calverley PM; Burge PS; Spencer S; Anderson JA; Jones PW
Thorax; 2003 Aug; 58(8):659-64. PubMed ID: 12885978
[TBL] [Abstract][Full Text] [Related]
33. Perception of bronchoconstriction in smokers with airflow limitation.
Ottanelli R; Rosi E; Ronchi MC; Grazzini M; Lanini B; Stendardi L; Romagnoli I; Bertini S; Duranti R; Scano G
Clin Sci (Lond); 2001 Nov; 101(5):515-22. PubMed ID: 11672457
[TBL] [Abstract][Full Text] [Related]
34. Airflow limitation in Japanese smokers: significance of serum neutrophil elastase/alpha(1)-proteinase inhibitor ratio and FEV(1) (%pred) adjusted by pack-years.
Hoshino Y; Nagai S; Koyama H; Okuda K; Nishimura K; Miki H; Hamada K; Izumi T
Respiration; 2000; 67(4):372-7. PubMed ID: 10940789
[TBL] [Abstract][Full Text] [Related]
35. COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT).
Morice AH; Celli B; Kesten S; Lystig T; Tashkin D; Decramer M
Respir Med; 2010 Nov; 104(11):1659-67. PubMed ID: 20724131
[TBL] [Abstract][Full Text] [Related]
36. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
37. Influence of predicted FEV1 on bronchodilator response in asthmatic patients.
Ouksel H; Meslier N; Badatcheff-Coat A; Racineux JL
Respiration; 2003; 70(1):54-9. PubMed ID: 12584392
[TBL] [Abstract][Full Text] [Related]
38. IL13 promoter polymorphism 1112C/T modulates the adverse effect of tobacco smoking on lung function.
Sadeghnejad A; Meyers DA; Bottai M; Sterling DA; Bleecker ER; Ohar JA
Am J Respir Crit Care Med; 2007 Oct; 176(8):748-52. PubMed ID: 17615386
[TBL] [Abstract][Full Text] [Related]
39. [Smoking cessation in patients with severe irreversible chronic obstructive pulmonary disease, "smoker's lung"].
Johansen DL; Larsen V; Langfrits U; Døssing M
Ugeskr Laeger; 1999 Jun; 161(24):3655-8. PubMed ID: 10485223
[TBL] [Abstract][Full Text] [Related]
40. [Validation of the Spanish version of the Chronic Obstructive Pulmonary Disease-Population Screener (COPD-PS). Its usefulness and that of FEV₁/FEV₆ for the diagnosis of COPD].
Miravitlles M; Llor C; Calvo E; Diaz S; Díaz-Cuervo H; Gonzalez-Rojas N
Med Clin (Barc); 2012 Nov; 139(12):522-30. PubMed ID: 22015009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
